Modification of BRCA1-associated breast cancer risk by HMMR overexpressionFrancesca Mateo, Miguel Ángel Pujana, Curtis W. McCloskey et al.|Nature Communications|2022Cited by 53
Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation CarriersIgnacio Blanco, Miguel de la Hoya, Karoline Kuchenbaecker et al.|PLoS ONE|2015Cited by 39
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Aslihan Ugun‐Klusek, Francesca Mateo et al.|EMBO Molecular Medicine|2021Cited by 21
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell StemnessGorka Ruíz de Garibay, Miguel Ángel Pujana, Carmen Herranz et al.|PLoS ONE|2015Cited by 20
Tumor xenograft modeling identifies TCF4/ITF2 loss associated with breast cancer chemoresistanceGorka Ruíz de Garibay, Miguel Ángel Pujana, Francesca Mateo et al.|Disease Models & Mechanisms|2018Cited by 18